ArticleTargeted oncology2019
Predictive Impact of Peripheral Blood Markers and C-Reactive Protein in Nivolumab Therapy for Metastatic Renal Cell Carcinoma.
Hiroki Ishihara et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
45 papers cite it
this paperpooled itcites it